Abstract:As the global incidence of breast cancer continues to surge, the pursuit of novel, low-toxicity, and highly efficacious therapeutic strategies has emerged as a pivotal research focus. Curcumin (CUR), an active constituent of traditional Chinese medicine (TCM) renowned for its antimicrobial, anti-inflammatory, antioxidant, and antitumor properties, exhibits immense potential in breast cancer therapy. Nevertheless, CUR's poor water solubility, chemical instability, and unfavorable pharmacokinetics have impeded its clinical utilization. To address these challenges, nano-delivery systems have been extensively exploited for CUR administration, enhancing its in vivo stability and bioavailability, and facilitating precise targeting of breast cancer lesions. Therefore, we elaborate on CUR's chemical foundations, drug metabolism, and safety profile, and elucidate its potential mechanisms in breast cancer therapy, encompassing inducing apoptosis and autophagy, blocking cell cycle, inhibiting breast cancer metastasis, regulating tumor microenvironment and reversing chemotherapy resistance. The review primarily emphasizes recent advancements in CUR-based nano-delivery systems for the treatment and diagnosis of breast cancer. Liposomes, nanoparticles (encompassing polymer nanoparticles, solid lipid nanoparticles, mesoporous silica particles, metal/metal oxide nanoparticles, graphene nanomaterials, albumin nanoparticles, etc.), nanogels, and nanomicelles can serve as delivery carriers for CUR, exhibiting promising anti-breast cancer effects in both in vivo and in vitro experiments. Furthermore, nano-CUR can be integrated with fluorescence imaging, magnetic resonance imaging, computed tomography imaging, ultrasound, and other techniques to achieve precise localization and diagnosis of breast cancer masses. While this article has summarized the clinical studies of nano-curcumin, it is noteworthy that the research literature on nano-CUR applied to breast cancer diagnosis and the translation of nano-CUR clinical studies in BC patients remain limited. Therefore, future research should intensify exploration in this direction.

The progresses in curcuminoids-based metal complexes: especially in cancer therapy.

Recent advances in the antioxidant activity of metal-curcumin complexes: a combined computational and experimental review

Metal–Curcumin Complexes in Therapeutics: An Approach to Enhance Pharmacological Effects of Curcumin

Zn(II)‐curcumin complexes‐based anticancer agents

Advances in Curcumin-Loaded Nanopreparations: Improving Bioavailability and Overcoming Inherent Drawbacks

The study of anticancer effects of curcumin derivatives and curcumin composites

Unique flower-like Cur-metal complexes loaded liposomes for primary and metastatic breast cancer therapy

Recent Progress in Studying Curcumin and Its Nano-preparations for Cancer Therapy

Recent Researches in Metal Supramolecular Complexes As Anticancer Agents.

Complexes of Zn( ii ) with a mixed tryptanthrin derivative and curcumin chelating ligands as new promising anticancer agents

Bifunctional Ruthenium(ii) Polypyridyl Complexes of Curcumin As Potential Anticancer Agents

Promotion of the Anticancer Activity of Curcumin Based on a Metal-Polyphenol Networks Delivery System

Prospects of Curcumin Nanoformulations in Cancer Management

Curcumin, its derivatives, and their nanoformulations: Revolutionizing cancer treatment

Review: Recent Advances and Future Development of Metal Complexes As Anticancer Agents

Interaction of curcumin with Zn(II) and Cu(II) ions based on experiment and theoretical calculation

Advances in Nanotechnology-Based Delivery Systems for Curcumin

Recent progress in bioactivities of curcumin derivatives

Curcumin and nanodelivery systems: New directions for targeted therapy and diagnosis of breast cancer

Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents.

Advancements in curcumin-loaded PLGA nanoparticle delivery systems: progressive strategies in cancer therapy